Gold nanoparticles - The theranostic challenge for PPPM: Nanocardiology application

EPMA Journal

Volumn 4, Issue 1, 2013, Pages

  Spivak, Mykola Ya ^a,b   Bubnov, Rostyslav V ^a,c   Yemets, Ilya M ^d   Lazarenko, Liudmyla M ^a   Tymoshok, Natalia O ^a   Ulberg, Zoia R ^e  

^a ZABOLOTNY INSTITUTE OF MICROBIOLOGY AND VIROLOGY   (Ukraine)

^b LCL DIAPROF   (Ukraine)

^c Clinical Hospital Pheophania of State Affairs Department   (Ukraine)

^d Cardiac Health of Ukraine   (Ukraine)

^e INSTITUTE OF BIOCOLLOID CHEMISTRY   (Ukraine)

Author keywords

Drug delivery; Gold nanoparticles; Nanomedicine; Predictive; Preventive and personalised medicine; Sonoporation; Theranostics

Indexed keywords

BIOLOGICAL MARKER; CERIUM OXIDE NANOPARTICLE; GOLD NANOPARTICLE; REACTIVE OXYGEN METABOLITE;

ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CARDIOLOGY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COATED PARTICLE; CONJUGATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; HYDROPHOBICITY; NANOFABRICATION; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PERSONALIZED MEDICINE; PHOTOACOUSTICS; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; PLASMID; POLYMERIZATION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; SURFACE CHARGE; SURFACE PROPERTY; THERANOSTIC NANOMEDICINE;

EID: 84961395940     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1186/1878-5085-4-18     Document Type: Review

References (115)

1. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M: Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002, 87(3):235–241.
2. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK: Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002, 23(23):1867–1876.
3. Neubauer S: The failing heart — an engine out of fuel. N Engl J Med 2007, 356(11):1140–1151.
4. Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI: Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000, 139(1 Pt 1):72–77.
5. Lanza GM, Winter PM, Caruthers SD, Hughes MS, Cyrus T, Marsh JN, Neubauer AM, Partlow KC, Wickline SA: Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Nanomedicine 2006, 1:321–329.
6. Golubnitschaja O, Costigliola V, EPMA: General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European association for predictive, preventive and personalised medicine. EPMA J 2012, 3:14.
7. Jain KK: Nanomedicine: application of nanobiotechnology in medical practice. Med Princ Pract 2008, 17(2):89–101.
8. Drucker E, Krapfenbauer K: Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J 2013, 4:7.
9. Feuerstein GZ, Dormer C Jr, Rufollo RR, Stiles G, Walsh FS, Rutkowski JL: Translational medicine perspectives of biomarkers in drug discovery and development. Part I. Target selection and validation - biomarkers take center stage. Int Drug Discovery 2007, 2(5):36–43.
10. Coelho J, Ferreira P, Alves P, Cordeiro R, Fonseca A, Góis J, Gil M: Drug delivery systems: advanced technologies potentially applicable in personalized treatments. EPMA J 2010, 1:164–209.
11. Boisselier E, Astruc D: Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38:1759–1782.
12. Tsai CY, Shiau AL, Cheng PC, Shieh DB, Chen DH, Chou CH, Yeh CS, Wu CL: A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity. Nano Lett 2004, 4:1209–1212.
13. Link S, El-Sayed MA: Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J Phys Chem B 1999, 103(40):8410–8426.
14. Link S, El-Sayed MA: Shape and size dependence of radiative, nonradiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem 2000, 19(3):409–453.
15. Link S, El-Sayed MA: Optical properties and ultrafast dynamics of metallic nanocrystals. Annu Rev Phys Chem 2003, 54:331–366.
16. Huang X, El-Sayed MA: Gold nanoparticles optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res 2010, 1:13–28.
17. Porter LA, Ji D, Westcott SL, Graupe M, Czernuszewicz RS, Halas NJ, Lee TR: Gold and silver nanoparticles functionalized by the adsorption of dialkyl disulfides. Langmuir 1998, 14:7378–7386.
18. Thompson DT: Using gold nanoparticles for catalysis. Nano Today 2007, 2:40–43.
19. Sperling RA, Gil PR, Zhang F, Zanella M: Biological applications of gold nanoparticles. Chem Soc Rev 2008, 37:1896–1908.
20. Faraji AH, Wipf P: Nanoparticles in cellular drug delivery. Bioorg Med Chem 2009, 17(8):2950–2962.
21. Faraday M: Experimental relations of gold (and other metals) to light. Philos Trans R Soc London 1857, 147:145.
22. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman JR: Synthesis of thiol derivatised gold nanoparticlesin a two phase liquid/liquid system. Chem Soc Chem Commun 1994, 7:801–802.
23. Higashi N, Kawahara J, Niwa M: Preparation of helical peptide monolayercoated gold nanoparticles. J. Colloid Interface Sci 2005, 288(1):83–87.
24. Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, Scheynius A, Gabrielsson S: The importance of an endotoxin-free environment during the production of nanoparticles used in medical application. Nano Lett 2006, 6(8):1682–1686.
25. Moolhuizen G, Paciotti GF, Leede LG, Tamarkin L: Colloidal gold nanoparticles. In Business Briefing. London: Pharmatech; 2004.
26. Moghimi SM, Hunter AC, Murray JC: Nanomedicine: current status and future prospects. FASEB J 2005, 19:311–330.
27. Praetorius NP, Mandal TK: Engineered nanoparticles in cancer therapy. Recent Pat Drug Deliv Formul 2007, 1:37–51.
28. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA: Selective colorimetric detection of polynucleotides based on the distancedependent optical properties of gold nanoparticles. Science 1997, 277:1078–1081.
29. Hawley AE, Davis SS, Illum L: Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev 1995, 17:129–148.
30. Asada K, Takahashi M: Production and scavenging of active oxygen in photosynthesis. In Photoinhibition. Edited by Kyle DJ, Osmond CB, Arntzen CJ. Amsterdam: Elsevier; 1987:227–287.
31. Barath Mani Kanth S, Kalishwaralal K, Sriram M, Pandian SRK, Youn H-S, Eom S, Gurunathan S: Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnol 2010, 8:16.
32. Alvaro M, Aprile C, Corma A, Ferrer B, Garcia H: Influence of radical initiators in gold catalysis: evidence supporting trapping of radicals derived from azobis(isobutyronitrile) by gold halides. J Catal 2006, 245:249–252.
33. Navalon S, Martin R, Alvaro M, Garcia H: Gold on diamond nanoparticles as a highly efficient Fenton catalyst. Angew Chem Int Ed Engl 2010, 49(45):8403–8407.
34. Hirst SM, Karakoti A, Singh S, Self W, Tyler R, Seal S, Reilly CM: Biodistribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol 2013, 28(2):107–118. doi:10.1002/tox.20704.
35. Hirst SM, Karakoti AS, Tyler RD, Sriranganathan N, Seal S, Reilly CM: Antiinflammatory properties of cerium oxide nanoparticles. Small 2009, 5(24):2848–2856.
36. Colon J, Hsieh N, Ferguson A, Kupelian P, Seal S, Jenkins DW, Baker CH: Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 2010, 6:698.
37. Wason MS, Zhao J: Cerium oxide nanoparticles: potential applications for cancer and other diseases. Am J Transl Res 2013, 5(2):126–131.
38. Alili L, Sack M, Karakoti AS, Teuber S, Puschmann K, Hirst SM, Reilly CM, Zanger K, Stahl W, Das S, Seal S, Brenneisen P: Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials 2011, 32:2918–2929.
39. Alili L, Sack M, von Montfort C, Giri S, Das S, Carroll K, Zanger K, Seal S, Brenneisen P: Downregulation of tumor growth and invasion by redoxactive nanoparticles. Antioxid Redox Signal 2013. doi:10.1089/ars.2012.4831.
40. Babenko LP, Zholobak NM, Shcherbakov AB, Voychuk SI, Lazarenko LM, Spivak MY: Antibacterial activity of cerium colloids against opportunistic microorganisms in vitro. Mikrobiol Z 2012, 74(3):54–62.
41. Zholobak NM, Olevinskaia ZM, Spivak NI, Shcherbakov AB, Ivanov VK, Usatenko AV: Antiviral effect of cerium dioxide nanoparticles stabilized by low-molecular polyacrylic acid. Mikrobiol Z 2010, 72(3):42–47. Russian.
42. Menchón C, Martín R, Apostolova N, Victor VM, Alvaro M, Herance JR, García H: Gold nanoparticles supported on nanoparticulate ceria as a powerful agent against intracellular oxidative stress. Small 2012, 8(12):1895–1903.
43. Tsai CY, Shiau AL, Chen SY, Chen YH, Cheng PC, Chang MY, Chen DH, Chou CH, Wang CR, Wu CL: Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum 2007, 56(2):544–554.
44. Selvakannan PR, Mandal S, Phadtare S, Pasricha R, Sastry M: Capping of gold nanoparticles by the amino acid lysine renders them waterdispersible. Langmuir 2003, 19:3545–3549.
45. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S: Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005, 11:3530–3534.
46. Bhattacharya R, Mukherjee P, Xiong Z, Atala A, Soker S, Mukhopadhyay D: Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano Lett 2004, 4:2479–2481.
47. Haes AJ, Hall WP, Chang L, Klein WL, Van Duyne RP: A localized surface plasmon resonance biosensor: first steps toward an Alzheimer's disease. Assa Nano Lett 2004, 4:1029–1034.
48. Haes AJ, Chang L, Klein WL, Van Duyne RP: Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor. J Am Chem Soc 2005, 127:2264–2271.
49. Bowman M-C, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM, Melander C: Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 2008, 130:6896–6897.
50. Xi D, Luo X, Ning Q, Lu Q, Yao K, Liu Z: The detection of HBV DNA with gold nanoparticle gene probes. J Nanjing Med Univ 2007, 21(4):207–212.
51. Baptista PV, Koziol-Montewka M, Paluch-Oles J, Doria G, Franco R: Goldnanoparticle- probe–based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin Chem 2006, 52:1433–1434.
52. Baptista P, Pereira E, Eaton P, Doria G, Miranda A, Gomes I, Quaresma P, Franco R: Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem 2008, 391(3):943–950.
53. Paleos CM, Tsiourvas D, Sideratou Z, Tziveleka L: Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system. Biomacromolecules 2004, 5:524–529.
54. Kisak ET, Coldren B, Evans CA, Boyer C, Zasadzinski JA: The vesosome— a multicompartment drug delivery vehicle. Curr Med Chem 2004, 11:199–219.
55. Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand JP, Gennaro R, Prato M, Bianco A: Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed 2005, 44:6358–6362.
56. Salem AK, Searson PC, Leong KW: Multifunctional nanorods for gene delivery. Nat Mater 2003, 2:668–671.
57. Brown SD, Nativo P, Smith J-A, Stirling D, Edwards PR, Venugopal B, Flint DJ, Plumb JA, Graham D, Wheate NJ: Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 2010, 132:4678–4684.
58. Ghosh P, Han G, De M, Kim CH, Rotello VM: Gold nanoparticles in delivery applications. Adv Drug Delivery Rev 2008, 60:1307–1315.
59. Edlund U, Albertsson AC: Polyesters based on diacid monomers. Adv Drug Deliv 2003, 55:585–609.
60. Lim SB, Ruminstein I, Onyuksel H: Freeze drying of peptide drugs selfassociated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles. Int J Pharm 2008, 356:345–350.
61. Ebessen M, Jensen TJ: Nanomedicine: techniques, potentials, and ethical implications. J Biomed Biotechnol 2006, 1:1–11.
62. Checkman IS: Nanopharmacology. Kyiv: Zadruha; 2011:424.
63. Yu-Hsin W, Ai-Ho L, Jia-Yu L, Cheng-Ru L, Cheng-Ham W, Tzu-Min L, Churng-Ren W, Pai-Chi L: Enhanced delivery of gold nanoparticles by acoustic cavitation for photoacoustic imaging and photothermal therapy. SPIE Proceedings 8581, Photons Plus Ultrasound: Imaging and Sensing: 2013 February 2; San Francisco 2013:858123. doi:10.1117/12.2005870.
64. Mittler R: Oxidative stress, antioxidants and stress tolerance. Trends Plant Sci 2002, 7(9):405–410.
65. Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino KB: In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf Biointerf 2008, 65(1):1–10.
66. Florence A: The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res 1997, 14(3):259–266.
67. Douglas S, Davies S, Illum L: Nanoparticles in drug delivery. CRC Crit Rev Ther Drug Carrier Syst 1987, 3(3):233–261.
68. Ganeshchandra S, Tomoda K, Makino K: Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf Biointerf 2008, 66(2):274–280.
69. Olivier JC: Drug transport to brain with targeted nanoparticles. Pharmacol Rev 2005, 57:173–185.
70. Fabian G: Persorption—the way of large sized corpuscle particles via the lymphatic system. Lymphology 1983, 16:43–48.
71. Volkheimer G, Schulz FH, Lindenau A, Beitz U: Persorption of metallic iron particles. Gut 1969, 10:32–33.
72. Schneider HJ, Dedek W, Grahl R, Mothes B, Uhlemann J, Schwarz H, Schwachulla G, Reuter H, Mohring M: Studies of the persorption of large particles from radio-labelled cation exchangers. Urol Int 1983, 38:116–120.
73. Volkheimer G, Schulz FH: The phenomenon of persorption. Digestion 1968, 1:213–218.
74. Toporova OK, Irodov DM, Bubnov RV, Kholodkova OL, Gulko TP, Ruban TP, Morgunov PV, Kordium VA: Intrahepatic ultrasound-mediated gene delivery. J Hepatol 2013, 58:S119. doi:10.1016/S0168-8278(13)60283-4.
75. Eghtedari M, Oraevsky A, Copland JA, Kotov NA, Conjusteau A, Motamedi M: High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system. Nano Lett 2007, 7(7):1914–1918.
76. Conversano F, Soloperto G, Greco A, Ragusa A, Casciaro E, Chiriacò F, Demitri C, Gigli G, Maffezzoli A, Casciaro S: Echographic detectability of optoacoustic signals from low-concentration PEG-coated gold nanorods. Int J Nanomedicine 2012, 7:4373–4389.
77. Pan D, Pramanik M, Senpan A, Ghosh S, Wickline SA, Wang LV, Lanza GM: Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons. Biomaterials 2010, 31:4088–4093.
78. Jain PK, El-Sayed IH, El-Sayed MA: Au nanoparticles target cancer. Nano Today 2007, 2:18–29.
79. Pan D, Pramanik M, Senpan A, Wickline SA, Wang LV, Lanza GM: A facile synthesis of novel self-assembled gold nanorods designed for nearinfrared imaging. J Nanosci Nanotechnol 2010, 10:8118–8123.
80. Song KH, Kim C, Maslov K, Wang LV: Noninvasive in vivo spectroscopic nanorod-contrast photoacoustic mapping of sentinel lymph nodes. Eur J Rad 2009, 70:227–231.
81. Mallidi S, Larson T, Tam J, Joshi PP, Karpiouk A, Sokolov K, Emelianov S: Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett 2009, 9(8):2825–2831.
82. Lu W, Huang Q, Ku G, Wen X, Zhou M, Guzatov D, Brecht P, Su R, Oraevsky A, Wang LV, Li C: Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials 2010, 31(9):2617–2626.
83. Li ML, Wang JC, Schwartz JA, Gill-Sharp KL, Stoica G, Wang LV: In-vivo photoacoustic microscopy of nanoshell extravasation from solid tumor vasculature. J Biomed Opt 2009, 14(1):010507.
84. Gibson JD, Khanal BP, Zubarev ER: Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 2007, 129:11653–11661.
85. Kogan MJ, Bastus NG, Amigo R, Grillo-Bosch D, Araya E, Turiel A, Labarta A, Giralt E, Puntes VF: Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett 2006, 6(1):110–115.
86. Shukla R, Chanda N, Zambre A, Upendran A, Katti K, Kulkarni RR, Nune SK, Casteel SW, Smith CJ, Vimal J, Boote E, Robertson JD, Kan P, Engelbrecht H, Watkinson LD, Carmack TL, Lever JR, Cutler CS, Caldwell C, Kannan R, Katti KV: Laminin receptor specific therapeutic gold nanoparticles (198AuNPEGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci USA 2012, 109(31):12426–12431.
87. Chen J, Wiley BJ, Xia Y: One-dimensional nanostructures of metals: largescale synthesis and some potential applications. Langmuir 2007, 23(8):4120–4129.
88. Kim K, Kim JH, Park H, Kim YS, Park K, Nam H, Lee S, Park JH, Park RW, Kim IS, Choi K, Kim SY, Park K, Kwon IC: Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring. J Control Release 2010, 146(2):219–227.
89. Stuchinskaya T, Moreno M, Cook MJ, Edwards DR, Russell DA: Targeted photodynamic therapy of breast cancer cells usingantibody– phthalocyanine–gold nanoparticle conjugates. Photochem Photobiol Sci 2011, 10:822–831.
90. Larguinho M, Baptista PV: Gold and silver nanoparticles for clinical diagnostics - from genomics to proteomics. J Proteomics 2012, 75(10):2811–2823.
91. Cheng C, Chang K-C, Chen C-S, Pijanowska DG: Biosensor with nano-gold particle modified pencil lead carbon electrode for long-term glucose monitoring of waste tree branch hydrolysis. J Chin Chem Soc 2011, 58(6):739–748.
92. Perrault SD, Chan WCW: In vivo assembly of nanoparticle components to improve targeted cancer imaging. Proc Nat Acad Sci USA 2010, 107:11194–11199.
93. Nam JM, Thaxton CS, Mirkin CA: Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003, 301:1884–1886.
94. Godin B, Sakamoto JH, Serda RE, Grattoni A, Bouamrani A, Ferrari M: Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol Sci 2010, 31(5):199–205.
95. Kong DF, Goldschmidt-Clermont PJ: Tiny solutions for giant cardiac problems. Trends Cardiovasc Med 2005, 15(6):207–211.
96. Chnari E, Nikitczuk JS, Uhrich KE, Moghe PV: Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL. Biomacromolecules 2006, 7:597–603.
97. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT: Controlled delivery of PDGFBB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006, 116:237–248.
98. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, Kamm RD, Grodzinsky AJ, Anversa P, Lee RT: Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA 2006, 103:8155–8160.
99. Sy JC, Davis ME: Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers. J Cardiovasc Transl Res 2010, 3(5):461–468.
100. Powrie F, Coffman RL: Cytokine regulation of T-cell function: potential for therapeutic intervention. Trends Pharmacol Sci 1993, 14(5):164–168.
101. Astry B, Harberts E, Moudgil KD: A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res 2011, 31(12):927–940.
102. Mill JG, Stefanon I, dos Santos L, Baldo MP: Remodeling in the ischemic heart: the stepwise progression for heart failure. Braz J Med Biol Res 2011, 44(9):890–898.
103. Bubnov RV: Evidence-based pain management: is the concept of integrative medicine applicable? EPMA J 2012, 3:13.
104. Bubnov R, Yevseenko V, Semeniv I: Ultrasound guided injections of platelets rich plasma for muscle injury in professional athletes. Comparative study. Med Ultrason 2013, 15(2):101–105.
105. Andrews RJ: Neuroprotection at the nanolevel – part I: introduction to nanoneurosurgery. Ann NY Acad Sci 2007, 1122:169–184.
106. Doggrell SA, Brown L: Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 1998, 39(1):89–105.
107. Kannel WB: Hypertension as a risk for cardiac events – epidemiological results of long-term studies. J Cardiovasc Pharmacol 1993, 21(Suppl 2):S27–S37.
108. Bubnov RV: The use of ultrasound equipment of general use for in vivo study of cerium dioxide nanoparticles introduction in mice. Ultrasound Med Biol 2011, 37(8):S162. doi:10.1016/j.ultrasmedbio.2011.05.750.
109. Spivak M, Bubnov R, Yemets I, Lazarenko L, Timoshok N, Vorobieva A, Mohnatyy S, Ulberg Z, Reznichenko L, Grusina T, Zhovnir V, Zholobak N: Doxorubicin dose for congestive heart failure modeling and the use of general ultrasound equipment for evaluation in rats. Longitudinal in vivo study. Med Ultrason 2013, 15(1):23–28.
110. Trikas A, Antoniades C, Latsios G, Vasiliadou K, Karamitros I, Tousoulis D, Tentolouris C, Stefanadis C: Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure. Eur J Heart Fail 2006, 8(8):804–809.
111. Seaton A, Tran L, Aitken R, Donaldson K: Nanoparticles, human health hazard and regulation. J R Soc Interface 2010, 7:119–129.
112. Murphy CJ, Gole AM, Hunyadi SE, Stone JW, Sisco P, Alkilany A, Hankins PL, Kinard B: Chemical sensing and imaging with metallic nanorods. Chem Comm 2008, 41:1721–1730.
113. Son SJ, Bai X, Lee SB: Inorganic hollow nanoparticles and nanotubes in nanomedicine. Part 2: imaging, diagnostic, and therapeutic applications. Drug Discov Today 2007, 12(15–16):657–653.
114. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M: Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644–10654.
115. Duffin R, Tran L, Brown D, Stone V, Donaldson K: Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 2007, 19(10):849–856.